CDP Equity

Renovit Digitizes Supply Chain Management with Ivalua

Retrieved on: 
Thursday, April 18, 2024
Communication, SNAM, Risk, CDP Equity, Online shopping

REDWOOD CITY, Calif., April 18, 2024 /PRNewswire/ -- Ivalua, a global leader in spend management, and PwC Italy today announced that Renovit has implemented Ivalua's Source-to-Pay platform.

Key Points: 
  • Ivalua's Source-to-Pay platform enables Renovit to improve and simplify supplier management operations and communication throughout its supply chain, increasing transparency and efficiency.
  • REDWOOD CITY, Calif., April 18, 2024 /PRNewswire/ -- Ivalua , a global leader in spend management, and PwC Italy today announced that Renovit has implemented Ivalua's Source-to-Pay platform.
  • Furthermore, by leveraging Ivalua's Risk Center functionalities, Renovit enhances its ability to monitor and minimize risks along its supply chain.
  • "Ivalua is thrilled to partner with Renovit to optimize its supply chain processes, increasing operational efficiency and visibility," said Andrea Cozzi, Country Sales Manager at Ivalua Italy.

Tau Group Closes €11 Million Extension to Series-B Round to Fuel Growth and Enhance Production Capacity

Retrieved on: 
Tuesday, January 30, 2024
Tau, WM, Overalls, Financial institution, Investment, Aluminium, Ecosystem, Growth, CVC, EUR, Transport, Copper, Economic development, CDP Equity, Renewable energy

Tau has successfully closed a €11 million extension to its Series-B funding round.

Key Points: 
  • Tau has successfully closed a €11 million extension to its Series-B funding round.
  • Tau Group stands at the forefront of the energy transition, specializing in the decarbonization of energy and electrification of transport.
  • The funds raised in this extension will propel Tau Group's growth trajectory, enhancing its ability to achieve ambitious goals.
  • Tau Group is a technology company at the core of energy transition, decarbonization of energy and electrification of transport.

Tau Group Closes €11 Million Extension to Series-B Round to Fuel Growth and Enhance Production Capacity

Retrieved on: 
Tuesday, January 30, 2024
Tau, WM, Overalls, Financial institution, Investment, Aluminium, Ecosystem, Growth, CVC, EUR, Transport, Copper, Economic development, CDP Equity, Renewable energy

Tau has successfully closed a €11 million extension to its Series-B funding round.

Key Points: 
  • Tau has successfully closed a €11 million extension to its Series-B funding round.
  • Tau Group stands at the forefront of the energy transition, specializing in the decarbonization of energy and electrification of transport.
  • The funds raised in this extension will propel Tau Group's growth trajectory, enhancing its ability to achieve ambitious goals.
  • Tau Group is a technology company at the core of energy transition, decarbonization of energy and electrification of transport.

GreenIT and Copenhagen Infrastructure Partners to develop three floating offshore wind farms in Italy with 2 GW capacity

Retrieved on: 
Wednesday, March 22, 2023
Latium, Copenhagen Infrastructure Partners, Partnership, CIP, Electricity, Carbon, Wind, Plant, CDP Equity, Eni, Cassa Depositi e Prestiti, Farm, Renewable energy, Civitavecchia, Principle of plenitude

The partnership strengthens its commitment to the Italian offshore wind floating industry with three new projects located approximately 30 km off the coasts of Latium and Sardinia.

Key Points: 
  • The partnership strengthens its commitment to the Italian offshore wind floating industry with three new projects located approximately 30 km off the coasts of Latium and Sardinia.
  • The three wind farms make the consortium one of the largest developers in the sector in Italy, with a pipeline totaling almost 3 GW, enough to satisfy the electricity consumption of around 2.5 million households.
  • ROME and MILAN, Italy and COPENHAGEN, Denmark, March 22, 2023 (GLOBE NEWSWIRE) -- GreenIT, the Italian renewable energy joint venture between Plenitude (Eni) and CDP Equity (CDP Group), and Copenhagen Infrastructure Partners (CIP) through its Flagship Funds have signed an agreement to develop three floating offshore wind projects in Latium and Sardinia.
  • The plants will be located on average roughly 30 km off from the coast and have an overall capacity of approximately 2 GW.

UNGUESS, Italian leader in crowdtesting, closes a funding round of over EUR 10 million led by Fondo Italiano d'Investimento

Retrieved on: 
Tuesday, January 24, 2023
Safety, MEF, IAG, Cremona, CDP Equity, ING, KPMG, Banco BPM, Student, Costa Cruises, ABI, Axa, BPER Banca, EUR, Ministry, UniCredit, Ministry of Economy and Finance (Italy), ESG, Certified Ethical Hacker, Sky Italia, SGR, Enel, Muppet Mobile Lab, Investment, Intesa Sanpaolo, Orrick, Herrington & Sutcliffe, Partnership, Bank, Cryptocurrency, Growth, Pirelli

MILAN, Jan. 24, 2023 /PRNewswire/ -- A fundraising round of over EUR 10 million for UNGUESS (https://unguess.io/it/), Italy's leading innovative crowdsourcing platform. The lead investor is Fondo Italiano d'Investimento SGR, through the Fondo Italiano Tecnologia e Crescita – "FITEC". In addition to FITEC, investors who supported UNGUESS in previous rounds participated in the capital increase: P101 SGR with its two funds Programma 103 and ITA500, managed on behalf of Azimut, Italian Angels for Growth (IAG), Club degli Investitori and Club Italia Investimenti 2.

Key Points: 
  • The lead investor is Fondo Italiano d'Investimento SGR, through the Fondo Italiano Tecnologia e Crescita – "FITEC".
  • UNGUESS is managed by a top-quality team and has already acquired and consolidated a large and first-class customer base".
  • Fondo Italiano manages 13 closed-end investment funds reserved for qualified investors, for over 2.8 billion euros and operates through direct and indirect investments (funds of funds).
  • Fondo Italiano considers sustainability a core value and is committed to integrating environmental, social and governance (ESG) criteria into its investment activities.

UNGUESS, Italian leader in crowdtesting, closes a funding round of over EUR 10 million led by Fondo Italiano d'Investimento

Retrieved on: 
Tuesday, January 24, 2023
Safety, MEF, IAG, Cremona, CDP Equity, ING, KPMG, Banco BPM, Student, Costa Cruises, ABI, Axa, BPER Banca, EUR, Ministry, UniCredit, Ministry of Economy and Finance (Italy), ESG, Certified Ethical Hacker, Sky Italia, SGR, Enel, Muppet Mobile Lab, Investment, Intesa Sanpaolo, Multimedia, Orrick, Herrington & Sutcliffe, Partnership, Bank, Cryptocurrency, Growth, Pirelli

MILAN, Jan. 24, 2023 /PRNewswire/ -- A fundraising round of over EUR 10 million for UNGUESS (https://unguess.io/it/), Italy's leading innovative crowdsourcing platform. The lead investor is Fondo Italiano d'Investimento SGR, through the Fondo Italiano Tecnologia e Crescita – "FITEC". In addition to FITEC, investors who supported UNGUESS in previous rounds participated in the capital increase: P101 SGR with its two funds Programma 103 and ITA500, managed on behalf of Azimut, Italian Angels for Growth (IAG), Club degli Investitori and Club Italia Investimenti 2.

Key Points: 
  • The lead investor is Fondo Italiano d'Investimento SGR, through the Fondo Italiano Tecnologia e Crescita – "FITEC".
  • UNGUESS is managed by a top-quality team and has already acquired and consolidated a large and first-class customer base".
  • Fondo Italiano manages 13 closed-end investment funds reserved for qualified investors, for over 2.8 billion euros and operates through direct and indirect investments (funds of funds).
  • Fondo Italiano considers sustainability a core value and is committed to integrating environmental, social and governance (ESG) criteria into its investment activities.

EQS-News: Evotec, CDP Venture Capital and Angelini Ventures launch translational partnership 'Extend' with leading Italian academic Institutions

Retrieved on: 
Friday, October 28, 2022
Transfer, Frankfurt Stock Exchange, Drug discovery, University, General manager, NASDAQ, Venture capital, Angelini, ISIN, Technology transfer, Efficiency, ESG, Mental health, CEO, Communication, Biomedical Research, Patient, Clinical research coordinator, Research, Twitter, Investment, Knowledge, Science, Partnership, Central nervous system, Innovation, Biotechnology, CDP Equity, LinkedIn, University of Milan, Growth, Wine, Economic development, Trematode life cycle stages, EVO, Leadership, Woman, Corporate venture capital, Therapy, MDAX, Pharma, Academy, Neurology, Industry, Quality of life, News, Security (finance), Cryptocurrency, Pharmaceutical industry, Risk management, Fine chemical, Management, Evotec

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced the launch of Extend, a translational BRIDGE partnership in cooperation with CDP Venture Capital Sgr, a strategic pillar to Italy's economic growth and innovation, and Angelini Ventures, the Corporate Venture Capital arm of the multi-business industrial group Angelini Industries.

Key Points: 
  • Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced the launch of Extend, a translational BRIDGE partnership in cooperation with CDP Venture Capital Sgr, a strategic pillar to Italy's economic growth and innovation, and Angelini Ventures, the Corporate Venture Capital arm of the multi-business industrial group Angelini Industries.
  • Extend is a joint venture between Evotec, CDP Venture Capital and Angelini Ventures to develop translational drug discovery partnerships with highly renowned universities and research centres in Italy.
  • Dr Werner Lanthaler, Chief Executive Officer of Evotec, commented: We are excited to launch Extend together with our partners at CDP Venture Capital and Angelini Ventures.
  • Extend brings together leading academic institutions from Italy to accelerate their most promising assets towards commercialisation.

Permira Funds and the Marcucci family complete investment in Kedrion and BPL and announce appointment of Ugo Di Francesco as CEO

Retrieved on: 
Thursday, September 1, 2022
Health care, Partnership, Bio Products Laboratory, Goodwin Procter, Novartis, ADIA, CEO, Abu Dhabi Investment Council, Trust, Ugo, Bristol Myers Squibb, Morgan Stanley, BPL, Marcucci, Leadiant Biosciences, Permira, Abu Dhabi Investment Authority, Giliberti, Goal, Acceleration, Partner, Health, BofA Securities, Plasma, Francesco Carnelutti, Human serum albumin, EY, FSI, Acquisition, TII, Industry, Growth, CDP Equity, Patient, Management, Fine chemical, Pharmaceutical industry

Ugo Di Francesco, currently CEO of Chiesi Group, has been appointed the new CEO of the combined company, effective January 2023.

Key Points: 
  • Ugo Di Francesco, currently CEO of Chiesi Group, has been appointed the new CEO of the combined company, effective January 2023.
  • Paolo Marcucci, co-founder of Kedrion, will continue as the combined company's Chairman and CEO until Ugo Di Francesco joins the business, and thereafter as non-executive Chairman.
  • Kedrion was established by the Marcucci family in 2001 but has roots in the Italian pharmaceutical industry dating back to the 1950s.
  • Kedrion shareholders were advised by Lazard, Natixis, Carnelutti and Pedersoli, whilst the Marcucci family was advised by Terzi&Partners and Carnelutti.

Permira Funds and the Marcucci family complete investment in Kedrion and BPL and announce appointment of Ugo Di Francesco as CEO

Retrieved on: 
Thursday, September 1, 2022
Health care, Partnership, Bio Products Laboratory, Goodwin Procter, Novartis, ADIA, CEO, Abu Dhabi Investment Council, Trust, Ugo, Bristol Myers Squibb, Morgan Stanley, BPL, Marcucci, Leadiant Biosciences, Permira, Abu Dhabi Investment Authority, Giliberti, Goal, Acceleration, Partner, Health, BofA Securities, Plasma, Francesco Carnelutti, Human serum albumin, EY, FSI, Acquisition, TII, Industry, Growth, CDP Equity, Patient, Management, Fine chemical, Pharmaceutical industry

Ugo Di Francesco, currently CEO of Chiesi Group, has been appointed the new CEO of the combined company, effective January 2023.

Key Points: 
  • Ugo Di Francesco, currently CEO of Chiesi Group, has been appointed the new CEO of the combined company, effective January 2023.
  • Paolo Marcucci, co-founder of Kedrion, will continue as the combined company's Chairman and CEO until Ugo Di Francesco joins the business, and thereafter as non-executive Chairman.
  • Kedrion was established by the Marcucci family in 2001 but has roots in the Italian pharmaceutical industry dating back to the 1950s.
  • Kedrion shareholders were advised by Lazard, Natixis, Carnelutti and Pedersoli, whilst the Marcucci family was advised by Terzi&Partners and Carnelutti.